China Health Holding Announces the Chief Executive Officer Investing $300,000.00 in the Company.LAS VEGAS Las Vegas (läs vā`gəs), city (1990 pop. 258,295), seat of Clark co., S Nev.; inc. 1911. It is the largest city in Nevada and the center of one of the fastest-growing urban areas in the United States. -- China Health Holding (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CHHH), a development-stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor in the global medical and pharmaceutical industry in China and worldwide, announced today the Company's Board on October 12, 2006, has approved to issue 10,000,000 shares of the Company's common stock to Julianna Lu, the Company's Founder and Chief Executive Officer, as consideration for the forgiveness of loans in the aggregate amount of $300,000 previously advanced to the Company by Ms. Lu. As additional consideration, the Company agreed to issue to Ms. Lu five year warrants to purchase 10,000,000 shares of the Company's common stock, exercisable at a price of $0.10 and ten year warrants to purchase 10,000,000 shares of the Company's common stock exercisable at a price of $0.20. The warrants have piggy back registration Piggy Back Registration When an underwriter allows existing holdings of a company's shares to be sold in conjunction with an offering of new public shares. Notes: rights with respect to the shares of common stock issuable upon exercise of the warrants. The Company claims an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") with respect to the foregoing, pursuant to Section 4(2) of the Act and/or Regulation D promulgated prom·ul·gate tr.v. prom·ul·gat·ed, prom·ul·gat·ing, prom·ul·gates 1. To make known (a decree, for example) by public declaration; announce officially. See Synonyms at announce. 2. thereunder. In 10 years, Julianna Lu's further warrants exercise will bring the Company for a total 3,800,000 USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. cash investment. Julianna Lu, the Founder/CEO, has substantially contributed to the Company financially and creatively in past years, with her full commitment/contribution/dedication to develop/advance the Company into a successful global pharmaceutical corporation and to the Public Shareholders, with the honorable goal for further improvement of The World Health and The World Pharmaceutical Industry. About China Health Holding China Health Holding, Inc. is a developer, manufacturer and marketer for natural medicinal products medicinal product, n a substance administered to humans or animals through injection, application, oral ingestion, inhalation, and so forth, whose purpose is to ultimately restore health or eliminate disease in an individual. and pharmaceutical drug pipeline worldwide, with an extensive knowledge and expertise in the field of Traditional Chinese Medicine Traditional Chinese Medicine Definition Traditional Chinese medicine (TCM) is an ancient and still very vital holistic system of health and healing, based on the notion of harmony and balance, and employing the ideas of moderation and prevention. and China Pharmaceutical Industry. CHHH's immediate goal is profitable penetration of the growing global and China pharmaceutical industry and market. Also to seek and develop and complete potential acquisition candidates with major pharmaceutical companies in PR China and worldwide to secure a strong future and powerful position in the global and PR China pharmaceutical industry. Long-term plans include the development of a pharmaceutical drug pipeline and technology based on the Company's access to the knowledge of Traditional Chinese Medicine and PR China pharmaceutical industry. CHHH is supported by two core, wholly owned subsidiaries Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. : 1. China Health World Pharmaceutical Corporation, which will develop, manufacture and commercialize natural medications for epidemic diseases Noun 1. epidemic disease - any infectious disease that develops and spreads rapidly to many people pest, pestilence, plague - any epidemic disease with a high death rate infectious disease - a disease transmitted only by a specific kind of contact and conditions related to mellitus, cardiovascular and cerebral-vascular system dysfunctions, and neurological disorders This is a list of major and frequently observed neurological disorders (e.g. Alzheimer's disease), symptoms (e.g.back pain), signs (e.g. aphasia) and syndromes (e.g. Aicardi syndrome). . 2. China Health World Trade Corporation, which will support CHHH in the areas of worldwide to develop China Health/CHHH's retain/franchise stores/infrastructure and worldwide branding, multimedia marketing and multi-channel distribution to global customers and markets. Recent Developments and Acquisition Progress: 1. The Company controls/owns exclusive worldwide ownership/rights for a total of 134 proprietary natural herbal herbal, early botanical book containing descriptions and illustrations of herbs and plants with their properties, chiefly those qualities that made them useful as medicines or condiments. Most of the herbals were written between c.1470 and c. medicinal medicinal /me·dic·i·nal/ (mi-dis´in-il) having healing qualities; pertaining to a medicine. me·dic·i·nal adj. Of, relating to, or having the properties of medicine. products/formulas as Two Natural Herbal Medicinal Product lines: King of Herbs products and Taoist Medicinal products. The Company is developing and execution for further worldwide branding, multimedia marketing and multi-channel distribution, and worldwide retail and franchise stores/infrastructure to global customers and markets. 2. CHHH has executed a definitive acquisition agreement to acquire 60% of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. 3. CHHH has executed a definitive acquisition agreement to acquire 100% of Shaanxi MeiChen Pharmaceuticals Co. Ltd. 4. CHHH recently entered into letters of intent to acquire 51% or more of the following pharmaceutical companies in PR China: i. Beijing Boran Pharmaceutical Co. Ltd. ii. Shaanxi Wanan Pharmaceuticals Co. Ltd. iii. Henan Tiankang Pharmaceuticals Co. Ltd. CHHH believes that the completion of these acquisitions will enable it to vertically integrate its operations from manufacturing, developing and marketing Chinese herbal-based medicinal products, as well as a pharmaceutical drug pipeline, to full distribution and marketing across PR China, therefore substantially increasing profit margins. Acquisitions should accelerate growth of revenues and earnings. A strategic combination of assets, net income, an enhanced pharmaceutical drug pipeline and technologies will accrete value to the Company and its shareholders. In addition, CHHH also recently signed a letter of intent with WangJing Hospital and the WangJing Hospital of China Academy of Chinese Medical Sciences, PR China, in order to develop the China International University of Traditional Chinese Medicine and the University Hospital for Traditional Chinese Medical Sciences. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking; all forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. , whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. . In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion